These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 6884419)
21. Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use. Rawson NS; Harding SR; Malcolm E; Lueck L J Clin Epidemiol; 1998 Dec; 51(12):1343-55. PubMed ID: 10086829 [TBL] [Abstract][Full Text] [Related]
22. Drug-induced aplastic anaemia and agranulocytosis. Incidence and mechanisms. Vincent PC Drugs; 1986 Jan; 31(1):52-63. PubMed ID: 3940848 [TBL] [Abstract][Full Text] [Related]
23. Maloprim-induced agranulocytosis and red-cell aplasia. Nicholls MD; Concannon AJ Med J Aust; 1982 Dec 11-25; 2(12):564-6. PubMed ID: 7162443 [No Abstract] [Full Text] [Related]
24. Phenylbutazone, oxyphenbutazone labeling revised. FDA Drug Bull; 1984 Dec; 14(3):23-4. PubMed ID: 6526172 [No Abstract] [Full Text] [Related]
25. [Early discovery and management of drug-induced disorders. 5) Adverse effects of drugs in the area of hematology]. Dan K Nihon Naika Gakkai Zasshi; 2007 Sep; 96(9):1888-92. PubMed ID: 17929427 [No Abstract] [Full Text] [Related]
26. Analgesic risks and pharmacoepidemiology. Faich GA JAMA; 1986 Oct; 256(13):1788. PubMed ID: 3747091 [No Abstract] [Full Text] [Related]
30. Relative incidence of agranulocytosis and aplastic anemia. Kaufman DW; Kelly JP; Issaragrisil S; Laporte JR; Anderson T; Levy M; Shapiro S; Young NS Am J Hematol; 2006 Jan; 81(1):65-7. PubMed ID: 16369972 [TBL] [Abstract][Full Text] [Related]